Further analysis of our clinical data showed that INHα expression is stronger in benign epithelium and stroma but not the G3/G4 regions of the prostate in patients with lymph node metastasis compared to those with organ-confined disease. Here, INHA is linked to metastatic malignant neoplasm in the lymph nodes.